Dr. Phull is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
92 2nd St
Hackensack, NJ 07601Phone+1 551-996-8704Fax+1 551-996-0582
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 2014 - 2017
Tufts University School of MedicineClass of 2014
Certifications & Licensure
NJ State Medical License 2021 - 2025
PA State Medical License 2018 - 2021
MA State Medical License 2014 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Outcomes of Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma Receiving Salvage Cytotoxic Therapy with Supportive Stem Cell Boost.Ayrton Bangolo, Samir Oza, Ronit Reich-Slotky, Aimee Chappell, David S Siegel
Current Stem Cell Research & Therapy. 2025-01-01 - Venetoclax in the Treatment of Multiple Myeloma: A Retrospective Analysis of 79 Patients.Eli Zolotov, Vanisha Patel, Yedidyah Weiss, Noa Biran, Pooja Phull
European Journal of Haematology. 2024-12-05 - Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myelo...Eli Zolotov, Maciej Kabat, Harsh Parmar, Palka Anand, Joshua Zenreich
Leukemia & Lymphoma. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
